argenx agrees to acquire Unnatural Products, adding macrocyclic peptide discovery engine
argenx announced a definitive agreement to acquire Unnatural Products, Inc., adding a macrocyclic peptide discovery engine to its immunology innovation capabilities. The company disclosed the deal in a release but did not include financial terms in the announcement. The move extends argenx's discovery platform beyond its existing immunology programs.
Source:
globenewswire.com: https://www.globenewswire.com/news-release/2026/11/09/3398049/0/en/argenx-to-acquire-unnatural-products-inc-adding-peptide-discovery-engine-to-broaden-immunology-capabilities.html
Not financial advice. For informational and educational purposes only.